Management of kidney cancer patients: 2018 guidelines of the Italian Medical Oncology Association (AIOM).

Maria Giuseppa Vitale, Sergio Bracarda, Laura Cosmai, Emanuele Crocetti, Giuseppe Di Lorenzo, Alberto Lapini, Alberto Mandressi, Giuseppe Martorana, Cristina Masini, Rodolfo Montironi, Cinzia Ortega, Rodolfo Passalacqua, Camillo Porta, Giuseppe Procopio, Pierangela Sepe, Luigia Romano, Giovanni Luigi Pappagallo, Giario Conti, Michele Guida, Guido MartignoniFranco Nolè, Sandro Pignata, Stefania Gori, Giacomo Cartenì

Research output: Contribution to journalArticle

Abstract

In the past two decades, the treatment landscape for patients with metastatic renal cell carcinoma has significantly changed thanks to the approval of several targeted molecular therapies (VEGF and mTOR inhibitors) and recently immune-checkpoint inhibitors. The Italian Association of Medical Oncology (AIOM) Renal Cell Cancer (RCC) Guidelines Panel has developed clinical guidelines to provide evidence-based information and recommendations to oncologists, urologists and all professionals involved in the management of patients with renal cell cancer.

Original languageEnglish
Pages (from-to)3-12
Number of pages10
JournalTumori
Volume105
Issue number4_suppl
DOIs
Publication statusPublished - Jul 1 2019

Keywords

  • AIOM
  • guidelines
  • Italian
  • recommendation
  • renal cell cancer

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Management of kidney cancer patients: 2018 guidelines of the Italian Medical Oncology Association (AIOM).'. Together they form a unique fingerprint.

  • Cite this

    Giuseppa Vitale, M., Bracarda, S., Cosmai, L., Crocetti, E., Di Lorenzo, G., Lapini, A., Mandressi, A., Martorana, G., Masini, C., Montironi, R., Ortega, C., Passalacqua, R., Porta, C., Procopio, G., Sepe, P., Romano, L., Luigi Pappagallo, G., Conti, G., Guida, M., ... Cartenì, G. (2019). Management of kidney cancer patients: 2018 guidelines of the Italian Medical Oncology Association (AIOM). Tumori, 105(4_suppl), 3-12. https://doi.org/10.1177/0300891619853392